Ollin Biosciences has raised $430M across 2 funding rounds on record, the most recent a Series B of $330M announced in Jun 2026.
That round is above the $21M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ollin Biosciences Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Ollin Biosciences Funding Rounds
Ollin Biosciences raised $100M in a Series A announced in Sep 2025.
9 months later, a Series B of $330M was announced in Jun 2026.
Ollin Biosciences Founders and Leadership Team
Contact details for the Ollin Biosciences team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Ollin Biosciences Funding Compared to Other Biotechnology Startups
Ollin Biosciences' latest round of $330M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ollin Biosciences in Biotechnology and Austin
Companies Similar to Ollin Biosciences
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other…
Dayra Therapeutics manufactures peptide based medicines.
Chirality Biosciences is a developer of chiral molecule separation technology enabling faster, safer, and…
Bexorg provides a technology platform for central nervous system drug discovery and development.
AeroRx Therapeutics is a biopharmaceutical company that developing proprietary, combination products.
OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for…
Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric…
SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune…
Enlaza Therapeutics is a biotechnology research company.
4TEEN4 Pharmaceuticals develops innovative therapies and biomarkers for diagnosis, prediction, and treatment…
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and…
Ollin Biosciences Funding FAQs
What does Ollin Biosciences do?
Ollin Biosciences operates as a clinical-stage biopharmaceutical company.
How much funding has Ollin Biosciences raised?
Ollin Biosciences has raised $430M across 2 rounds on record. The most recent is a Series B of $330M announced in Jun 2026.
When did Ollin Biosciences last raise funding?
Ollin Biosciences' most recent funding round on record is a Series B of $330M, announced in Jun 2026.
Where is Ollin Biosciences headquartered?
Ollin Biosciences is based in Austin, United States.
How many employees does Ollin Biosciences have?
Ollin Biosciences is in the 11-50 employee band.
How does Ollin Biosciences' funding compare to other Biotechnology startups?
Ollin Biosciences' latest round of $330M is above the $21M median round size for Biotechnology companies on FundedIQ across 29 tracked companies over the last two years.
About FundedIQ's Ollin Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ollin Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.